If you have been prescribed PAXLOVID, you may be eligible for support resources through PAXCESS so you can get your PAXLOVID
prescription as soon as possible.
For eligible patients, the PAXCESS Patient Support Program offers personalized resources to help you get your prescribed PAXLOVID by providing:
- Insurance verification
- Help with identifying financial assistance resources for eligible patients
- Assistance with enrollment, if eligible
- Live PAXCESS representatives who can help you understand your insurance benefits and co-pay program eligibility
If you are commercially insured, pay as little as $0* for your PAXLOVID prescription.
- Enroll in the Co-Pay Savings Program
- Already have a co-pay card? Call 1-877-C19-PACK
(1-877-219-7225)to activate your card and unlock your co-pay savings
- Fill out a rebate form to potentially be reimbursed for your prescription
*Eligible commercially insured patients can save up to $1,500 per prescription. Maximum annual savings up to $1,500. Terms and conditions apply. Full terms and conditions for the Co-Pay Program may be found here.
PAXLOVID is authorized for
- PAXLOVID has not been approved, but has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in pediatric patients (12 years of age and older weighing at least 40 kg) who are at high risk for progression to severe COVID-19, including hospitalization or death.
- The emergency use of PAXLOVID is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization revoked sooner.
For patients who don’t meet the requirements for the PAXCESS Co-Pay Savings Program, other resources may be available.
If you rely on Medicare or Medicaid for your health insurance coverage or if you are uninsured, you may qualify for help through the USG PAP operated by Pfizer.
To qualify for free PAXLOVID through the program until December 31, 2024, patients must be:
- Uninsured and do not have a prescription drug benefit at the time they fill their prescription
- Medicare beneficiaries
- Medicaid beneficiaries
†With a focus on ensuring access for patients, the U.S. Government Patient Assistance Program (USG PAP) operated by Pfizer will continue to provide patients on Medicare, Medicaid, TRICARE, VA Community Care Network, and those who are uninsured access to PAXLOVID for free through December 31, 2024. PAXLOVID through the USG PAP is not available to patients who have commercial prescription drug health insurance. The USG PAP operated by Pfizer is an independent program with separate eligibility requirements offered by the United States Department of Health and Human Services and is not owned by Pfizer. Terms and conditions apply. Full terms and conditions for the USG PAP may be found here.
‡Exceptions for overnight orders include but may not be limited to: 3PM ET cutoff for placing orders; delivery and order processing not available on Sunday.